PAR · ALMKT.PA
Mauna Kea Technologies S.A.
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
Loading market information…
PAR · ALEMG.PA · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:09 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Euromedis Groupe’s quoted price sits in the upper half of its reported 52-week range, 9.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Euromedis Groupe’s forward annual dividend is €0.09 per share, paid annual. The forward yield is 1.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Euromedis Groupe’s next earnings report is currently expected on Mar 3, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Euromedis Groupe’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Euromedis Groupe, a French company established in 1985 and based in Mouy, France, specializes in the development, manufacturing, and distribution of medical equipment. Operating under its proprietary Euromedis brand, the company caters to a broad clientele in France, including medical professionals, local public services, and private individuals. Its extensive product line encompasses a wide array of medical supplies. This includes sterile and non-sterile gloves, wound care essentials like dressings and compresses, and various medical kits. For parenteral care, it provides items such as needles, syringes, infusers, and catheters. The surgical range is comprehensive, featuring wound drainage products, probes, draping solutions for operating theaters, surgical gloves, and protective covers. Beyond these, Euromedis also offers oxygen therapy equipment, products for continence management and general hygiene, diagnostic tools, and a selection of home care necessities. In addition to its product offerings, Euromedis Groupe provides services such as the distribution and rental of medical equipment, as well as specialized in-home infusion and nutrition support. While primarily focused on the French market, the company has a significant international footprint, exporting its products to numerous countries including Belgium, Italy, Morocco, Ivory Coast, Gabon, Benin, Algeria, Ireland, the Netherlands, Portugal, Tunisia, Switzerland, the Czech Republic, the United Kingdom, Germany, Finland, Spain, Greece, Hungary, Lithuania, Latvia, Bulgaria, and Poland.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
€0.85+€0.01 (+1.19%)
Biosynex S.A.’s quoted price sits in the lower half of its reported 52-week range, 45.86% below the high.
€0.14+€0.02 (+16.5%)
TME Pharma N.V.’s quoted price sits in the upper half of its reported 52-week range, 19.93% below the high.
€0.20-€0.00 (-0.98%)
Intrasense S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.11% below the high.
€0.09+€0.00 (+4.0%)
SpineGuard S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.88% below the high.
€0.10-€0.00 (-2.44%)
AMA Corporation Plc’s quoted price sits in the lower half of its reported 52-week range, 50.98% below the high.
€2.20€0.00 (0.0%)
Media Lab S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
€3.74-€0.20 (-5.08%)
Plant Advanced Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.79% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
